BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12018997)

  • 1. Influence of the a-ring on the redox and nuclease properties of the prodigiosins: importance of the bipyrrole moiety in oxidative DNA cleavage.
    Melvin MS; Calcutt MW; Noftle RE; Manderville RA
    Chem Res Toxicol; 2002 May; 15(5):742-8. PubMed ID: 12018997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the a-ring on the proton affinity and anticancer properties of the prodigiosins.
    Melvin MS; Tomlinson JT; Park G; Day CS; Saluta GR; Kucera GL; Manderville RA
    Chem Res Toxicol; 2002 May; 15(5):734-41. PubMed ID: 12018996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products.
    Manderville RA
    Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):195-218. PubMed ID: 12678767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tautomeric equilibria in phenolic A-ring derivatives of prodigiosin natural products.
    La JQ; Michaelides AA; Manderville RA
    J Phys Chem B; 2007 Oct; 111(40):11803-11. PubMed ID: 17867672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper-nuclease efficiency correlates with cytotoxicity for the 4-methoxypyrrolic natural products.
    Melvin MS; Wooton KE; Rich CC; Saluta GR; Kucera GL; Lindquist N; Manderville RA
    J Inorg Biochem; 2001 Dec; 87(3):129-35. PubMed ID: 11730894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc and copper complexes of prodigiosin: implications for copper-mediated double-strand DNA cleavage.
    Park G; Tomlinson JT; Melvin MS; Wright MW; Day CS; Manderville RA
    Org Lett; 2003 Jan; 5(2):113-6. PubMed ID: 12529118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper-obatoclax derivative complexes mediate DNA cleavage and exhibit anti-cancer effects in hepatocellular carcinoma.
    Su JC; Chang JH; Huang JW; Chen PP; Chen KF; Tseng PH; Shiau CW
    Chem Biol Interact; 2015 Feb; 228():108-13. PubMed ID: 25598309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and immunosuppressive activity of novel prodigiosin derivatives.
    D'Alessio R; Bargiotti A; Carlini O; Colotta F; Ferrari M; Gnocchi P; Isetta A; Mongelli N; Motta P; Rossi A; Rossi M; Tibolla M; Vanotti E
    J Med Chem; 2000 Jun; 43(13):2557-65. PubMed ID: 10891115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of nonylprodigiosin and macrocyclic prodigiosin analogues.
    Fürstner A; Grabowski J; Lehmann CW; Kataoka T; Nagai K
    Chembiochem; 2001 Jan; 2(1):60-8. PubMed ID: 11828428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper(II) complexes of 1,10-phenanthroline-derived ligands: studies on DNA binding properties and nuclease activity.
    Hirohama T; Kuranuki Y; Ebina E; Sugizaki T; Arii H; Chikira M; Tamil Selvi P; Palaniandavar M
    J Inorg Biochem; 2005 May; 99(5):1205-19. PubMed ID: 15833344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoinduced cytotoxicity and thioadduct formation by a prodigiosin analogue.
    Tomlinson JT; Park G; Misenheimer JA; Kucera GL; Hesp K; Manderville RA
    Org Lett; 2006 Oct; 8(21):4951-4. PubMed ID: 17020344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prodigiosin from the roseophilin producer Streptomyces griseoviridis.
    Kawasaki T; Sakurai F; Hayakawa Y
    J Nat Prod; 2008 Jul; 71(7):1265-7. PubMed ID: 18553921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoloprodigiosins from the C-10 bipyrrolic precursor: new antiproliferative prodigiosin analogs.
    Baldino CM; Parr J; Wilson CJ; Ng SC; Yohannes D; Wasserman HH
    Bioorg Med Chem Lett; 2006 Feb; 16(3):701-4. PubMed ID: 16289814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative cleavage of DNA by a dipyridoquinoxaline copper(II) complex in the presence of ascorbic acid.
    Santra BK; Reddy PA; Neelakanta G; Mahadevan S; Nethaji M; Chakravarty AR
    J Inorg Biochem; 2002 Apr; 89(3-4):191-6. PubMed ID: 12062122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prodigiosins: a new family of anticancer drugs.
    Montaner B; Pérez-Tomás R
    Curr Cancer Drug Targets; 2003 Feb; 3(1):57-65. PubMed ID: 12570661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry and biology of roseophilin and the prodigiosin alkaloids: a survey of the last 2500 years.
    Fürstner A
    Angew Chem Int Ed Engl; 2003 Aug; 42(31):3582-603. PubMed ID: 12916029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrochemical oxidation of ochratoxin A: correlation with 4-chlorophenol.
    Calcutt MW; Gillman IG; Noftle RE; Manderville RA
    Chem Res Toxicol; 2001 Sep; 14(9):1266-72. PubMed ID: 11559042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on DNA cleavage by cytotoxic pyrrole alkaloids reveal the distinctly different behavior of roseophilin and prodigiosin derivatives.
    Fürstner A; Grabowski EJ
    Chembiochem; 2001 Sep; 2(9):706-9. PubMed ID: 11828508
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and anti-cancer activity of C-ring-functionalized prodigiosin analogues.
    Regourd J; Ali AA; Thompson A
    J Med Chem; 2007 Apr; 50(7):1528-36. PubMed ID: 17348639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures, spectra, and DNA-binding properties of mixed ligand copper(II) complexes of iminodiacetic acid: the novel role of diimine co-ligands on DNA conformation and hydrolytic and oxidative double strand DNA cleavage.
    Selvakumar B; Rajendiran V; Uma Maheswari P; Stoeckli-Evans H; Palaniandavar M
    J Inorg Biochem; 2006 Mar; 100(3):316-30. PubMed ID: 16406550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.